Related Experiment Video

Updated: Aug 11, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation

Aaron Cranston1, Cristiana Carniti, Sam Martin

  • 1Cambridge Institute for Medical Research, Cancer Research UK Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XY, UK. aaron.cranston@ntlworld.com

Molecular Endocrinology (Baltimore, Md.)
|February 14, 2006
PubMed

Insights

A novel RET proto-oncogene mutation (R833C) was found in thyroid cancer. This mutation weakly activates RET, sustaining cancer growth but not metastasis, offering new insights into RET signaling in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RET proto-oncogene plays a crucial role in various cancers, including thyroid carcinoma.
  • Activating mutations in RET tyrosine kinase are key drivers in tumorigenesis.
  • Understanding specific mutations and their functional consequences is vital for targeted therapies.

Observation:

  • A novel missense mutation, R833C, was identified in the RET tyrosine kinase domain in a thyroid carcinoma patient.
  • This mutation was specifically linked to the long 3' splice isoform of RET.
  • Glial cell line-derived neurotrophic factor (GDNF) stimulation enhanced RET(R833C) activation.

Findings:

  • The R833C mutation confers a weak activating potential to RET, distinct from previously identified mutations like V804M and S891A.
  • In vitro, RET(R833C) demonstrated weak intrinsic kinase activity and did not significantly phosphorylate exogenous substrates, even with GDNF stimulation.
  • While R833C sustained the transformed phenotype in vivo, it did not enhance the invasive properties associated with metastasis, such as basement membrane degradation.

Implications:

  • This study is the first to demonstrate activation of RET by an intracellular cysteine residue.
  • The R833C mutation's weak activation potential and lack of metastatic enhancement provide a nuanced understanding of RET oncogenesis.
  • Further research into RET signaling pathways and specific mutation effects could lead to more precise therapeutic strategies for RET-driven cancers.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...